Answers are grounded in this paper and cite their sources.
Diabetic dyslipidemia may flag future diabetes and CVD risk; leaves open causal lipoprotein pathways for targeted study.
More cardiovascular disease occurs in patients with either type 1 or 2 diabetes. The link between diabetes and atherosclerosis is, however, not completely understood. Among the metabolic abnormalities that commonly accompany diabetes are disturbances in the production and clearance of plasma lipoproteins. Moreover, development of dyslipidemia may be a harbinger of future diabetes. A characteristic pattern, termed diabetic dyslipidemia, consists of low high density lipoprotein (HDL), increased triglycerides, and postprandial lipemia. This pattern is most frequently seen in type 2 diabetes and may be a treatable risk factor for subsequent cardiovascular disease. The pathophysiological alterations in diabetes that lead to this dyslipidemia will be reviewed in this article.
No takes yet. Share an insight, caveat, or question.
Ira J. Goldberg (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: